ArticleThe British journal of dermatology2022

Response to: 'Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT)': reply from the authors.

S Cro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.